Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant (NCT00114101)
A Phase III Randomized, Double-Blind Study of Maintenance Therapy With CC-5013 (NSC # 703813) or Placebo Following Autologous Stem Cell Transplantation for Multiple Myeloma
🩺 Plain-English Summary (8th-Grade Level)
This randomized phase III trial studies lenalidomide to see how well it works compared to a placebo in treating patients with multiple myeloma who are undergoing autologous stem cell transplant. Giving chemotherapy before a peripheral blood stem cell transplant helps kill any cancer cells that are in the body and helps make room in the patient's bone marrow for new blood-forming cells (stem cells) to grow. After treatment, stem cells are collected from the patient's blood and stored. More chemotherapy is then given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy. Biological therapies, such as lenalidomide, may stimulate or suppress the immune system in different ways and stop cancer cells from growing. Giving lenalidomide after autologous stem cell transplant may be an effective treatment for multiple myeloma.
Who can join: Review the eligibility criteria below.
Location: Mayo Clinic in Arizona — Scottsdale, Arizona
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (140 Sites)
Showing the first 25 of 140 sites.
- Mayo Clinic in Arizona — Scottsdale, Arizona
- City of Hope Comprehensive Cancer Center — Duarte, California
- University of California Davis Comprehensive Cancer Center — Sacramento, California
- UC San Diego Medical Center - Hillcrest — San Diego, California
- UCSF Medical Center-Mount Zion — San Francisco, California
- The Medical Center of Aurora — Aurora, Colorado
- Boulder Community Foothills Hospital — Boulder, Colorado
- Penrose-Saint Francis Healthcare — Colorado Springs, Colorado
- AdventHealth Porter — Denver, Colorado
- Presbyterian - Saint Lukes Medical Center - Health One — Denver, Colorado
- Saint Joseph Hospital - Cancer Centers of Colorado — Denver, Colorado
- Rose Medical Center — Denver, Colorado
- Western States Cancer Research NCORP — Denver, Colorado
- Swedish Medical Center — Englewood, Colorado
- Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado
- Banner North Colorado Medical Center — Greeley, Colorado
- CommonSpirit Saint Anthony Hospital Cancer Center — Lakewood, Colorado
- Sky Ridge Medical Center — Lone Tree, Colorado
- Longmont United Hospital — Longmont, Colorado
- Banner North Colorado Medical Center - Loveland Campus — Loveland, Colorado
- Saint Mary Corwin Medical Center — Pueblo, Colorado
- North Suburban Medical Center — Thornton, Colorado
- Intermountain Health Lutheran Hospital — Wheat Ridge, Colorado
- Beebe Medical Center — Lewes, Delaware
- Christiana Care Health System-Christiana Hospital — Newark, Delaware
📞 Contact the Study Coordinator
Phone: (800) 664-4580
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in DS Stage I Multiple Myeloma
Explore by condition: All DS Stage I Multiple Myeloma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.